RCA
BMY icon

Ranch Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Ranch Capital Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$347K Hold
5,726
– – 0.13% 122
2025
Q4 		$309K Sell
5,726
-202
-3% -$9.72K 0.11% 127
2025
Q3 		$267K Sell
5,928
-29,722
-83% -$1.39M 0.1% 134
2025
Q2 		$1.65M Buy
35,650
+1,511
+4% +$74.2K 0.72% 46
2025
Q1 		$2.08M Buy
34,139
+1,781
+6% +$104K 0.99% 36
2024
Q4 		$1.83M Buy
32,358
+1,162
+4% +$64.9K 0.86% 36
2024
Q3 		$1.61M Buy
31,196
+26,013
+502% +$1.22M 0.76% 42
2024
Q2 		$215K Buy
5,183
+3
+0.1% +$134 0.11% 139
2024
Q1 		$281K Buy
5,180
+3
+0.1% +$153 0.15% 126
2023
Q4 		$266K Sell
5,177
-26
-0.5% -$1.36K 0.17% 122
2023
Q3 		$302K Sell
5,203
-101
-2% -$6.19K 0.21% 110
2023
Q2 		$339K Hold
5,304
– – 0.24% 106
2023
Q1 		$368K Sell
5,304
-29
-0.5% -$2.04K 0.27% 105
2022
Q4 		$384K Hold
5,333
– – 0.3% 97
2022
Q3 		$379K Buy
5,333
+1
+0% +$73 0.31% 97
2022
Q2 		$411K Buy
5,332
+2
+0% +$152 0.32% 94
2022
Q1 		$389K Buy
5,330
+2
+0% +$134 0.26% 105
2021
Q4 		$332K Buy
5,328
+1
+0% +$59 0.22% 116
2021
Q3 		$315K Buy
+5,327
New +$351K 0.2% 122
2021
Q2 		– Sell
-5,419
Closed -$353K – 119
2021
Q1 		$342K Sell
5,419
-83
-2% -$5.16K 0.23% 111
2020
Q4 		$341K Sell
5,502
-1,118
-17% -$68.7K 0.25% 104
2020
Q3 		$399K Sell
6,620
-11,278
-63% -$679K 0.32% 89
2020
Q2 		$1.11M Buy
17,898
+1,511
+9% +$90.4K 0.87% 21
2020
Q1 		$913K Buy
16,387
+11,609
+243% +$710K 0.9% 21
2019
Q4 		$307K Sell
4,778
-33
-0.7% -$1.89K 0.25% 112
2019
Q3 		$244K Buy
+4,811
New +$226K 0.26% 116

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ranch Capital Advisors's BMY Position: Q1 2026 in Review

Ranch Capital Advisors held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 5,726 shares worth $347K. The position accounts for 0.13% of the portfolio, ranked #122.

Ranch Capital Advisors first reported a position in BMY in Q3 2019 and has held it in 26 quarters since. The position peaked at $2.08M in Q1 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Ranch Capital Advisors held 5,726 shares of Bristol-Myers Squibb worth $347K as of Q1 2026.
  • Ranch Capital Advisors left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.13% of Ranch Capital Advisors's portfolio in Q1 2026, its #122 holding.
  • Ranch Capital Advisors first reported a position in Bristol-Myers Squibb in Q3 2019 and has held it in 26 quarters since.
  • Ranch Capital Advisors's Bristol-Myers Squibb position peaked at $2.08M in Q1 2025.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Ranch Capital Advisors's 13F filing for Q1 2026, filed 6 May 2026.